Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    653 - Are there any limitations for using Phase II studies as support for therapeutic claims, apart from disclosing the Phase II nature?

    Claims & Support/References for Claims
    1
    1
    53
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • Jennifer Carroll
      Jennifer Carroll last edited by

      Whether you are using a Phase II or a Phase III study to support therapeutic claims in advertising, the same standards apply:

      • Clinical or therapeutic claims must be based on published, peer-reviewed, controlled and well-designed studies with clinical and statistical significance clearly indicated. The study (and the claim you wish to base on the study) must meet all relevant criteria listed in the PAAB code and the PAAB guidances.

      • The study must be consistent with and within the limitations of the TMA The PAAB code does not specifically differentiate between phase II and phase III studies. Having said, keep in mind that phase III studies are much more likely to meet all the criteria listed in the PAAB code and PAAB guidances than phase II studies. If unsure of the acceptability of a study as the evidentiary basis for a particular claim, consider submitting a opinion request (see the fee schedule on our website).

      1 Reply Last reply Reply Quote 0
      • First post
        Last post